Methodological and clinical considerations regarding lipoprotein(a) risk assessment in secondary prevention-authors' reply [0.03%]
关于二次预防中脂蛋白(a)风险评估的方法学和临床考量——作者回信
Jose V F de Mira,Isabella Kardys,Eric Boersma
Jose V F de Mira
Bernardo F Spiazzi,Carolina P Zingano,Luke J Laffin
Bernardo F Spiazzi
Target Trial Emulation of Alcohol Intake Interventions in Young Adults and Risk of CVD over 30 years: Data from the CARDIA study [0.03%]
基于CARDIA研究数据的饮酒干预降低年轻人30年心血管病风险的目标试验模拟研究
Jiarui Li,Luohua Jiang,David S Timberlake et al.
Jiarui Li et al.
Aim: This study uses a target trial emulation framework to estimate how different hypothetical sustained alcohol intake patterns affect 30-year cardiovascular disease risk in young adults. ...
Lipoprotein(a) and residual cardiovascular risk in statin-treated patients [0.03%]
他汀治疗患者的脂蛋白(a)与剩余心血管风险
Sam-Lennart Oftadeh,Andreas Pütz,Malte Jacobsen et al.
Sam-Lennart Oftadeh et al.
Aims: This study assessed the risk associated with moderately elevated lipoprotein(a) (Lp[a]) levels below current thresholds in a statin-treated population and explored possible differences in the effect of Lp(a) between...
Accelerated Vascular Ageing: An Early Prognostic Signal for Risk Stratification and Prevention [0.03%]
血管老化加速：风险分层和预防的早期预判信号
Catherine Liao,Carmel M McEniery,Ian B Wilkinson et al.
Catherine Liao et al.
Vascular ageing develops across the life course and contributes to cardiovascular, renal, cognitive, and pregnancy-related disease. It reflects cumulative exposure to pulsatile haemodynamic stress acting on the arterial wall and biological ...
Response to: Elevated Lipoprotein(a) Should Not Be Included in the Phenotypic Spectrum of Childhood Hypercholesterolemia: A Discussion Based on the 2023 IAS Guidelines [0.03%]
对《儿童高胆固醇血症表型谱系不应包括脂蛋白(a)水平升高——基于2023年IAS指南的讨论》一文的回应
Matej Mlinaric,Ana Drole Torkar,Urh Groselj
Matej Mlinaric
Prevention, mentorship, and meaning: an interview with Professor Emeline Van Craenenbroeck [0.03%]
预防、指导和意义：与伊拉斯谟大学法学院范克雷恩布罗埃克教授交流
Mayank Dalakoti,Emeline Van Craenenbroeck
Mayank Dalakoti
Guido Claessen,Alessandro Biffi,Xavier Bigard et al.
Guido Claessen et al.
Correction to: Circulating ketone bodies and risk of incident atrial fibrillation: insights from the MESA and UK Biobank cohorts [0.03%]
Correction to：循环酮体与阵发性房颤发病风险关联的研究——来自MESA和英国生物样本库的见解
Published Erratum
European journal of preventive cardiology. 2026 Jun 2:zwag286. DOI:10.1093/eurjpc/zwag286 2026